Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse of Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02265731
What this trial is testing

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)Chronic Lymphocytic Leukemia (CLL)+2 more
AbbVie 38
Testing effectiveness (Phase 2)Study completedNCT02193958
What this trial is testing

Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
AMLCMMLMDS
Fujifilm Pharmaceuticals U.S.A., Inc. 55
Testing effectiveness (Phase 2)Study completedNCT02458235
What this trial is testing

Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoid LeukemiaJuvenile Myelomonocytic Leukemia+1 more
University of California, San Francisco 17
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Ended earlyNCT01796470
What this trial is testing

Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+1 more
Gilead Sciences 66
Early research (Phase 1)Ended earlyNCT03051035
What this trial is testing

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Who this might be right for
Advanced Malignant Neoplasm
Kura Oncology, Inc. 61
Early research (Phase 1)Study completedNCT01551524
What this trial is testing

Phase I Study of mPEG-R-Crisantaspase Given IV

Who this might be right for
Hematologic Malignancies
Jazz Pharmaceuticals 36
Testing effectiveness (Phase 2)WithdrawnNCT02343679
What this trial is testing

Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies

Who this might be right for
Hematologic Malignancies
Anne Beaven, MD
Testing effectiveness (Phase 2)Study completedNCT00003913
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)Study completedNCT03097770
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Early research (Phase 1)Study completedNCT04136756
What this trial is testing

NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaIndolent Non-Hodgkin Lymphoma
Nektar Therapeutics 30
Not applicableLooking for participantsNCT05237986
What this trial is testing

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Who this might be right for
LymphomaLeukemia
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT01009931
What this trial is testing

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies

Who this might be right for
Leukemia
Rutgers, The State University of New Jersey 1
Testing effectiveness (Phase 2)UnknownNCT03185494
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 30
Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT02064387
What this trial is testing

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 79
Testing effectiveness (Phase 2)Study completedNCT00732316
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Asan Medical Center 54
Not applicableStudy completedNCT05397132
What this trial is testing

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Duke University 88
Next Page